AARD Company Profile and Key Details

NASDAQ : AARD

Aardvark Therapeutics Common Stock

$5.00

-0.28-5.30%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Aardvark Therapeutics, Inc. Common Stock (AARD) stock declined over -5.30%, trading at $5.00 on NASDAQ, down from the previous close of $5.28. The stock opened at $5.33, fluctuating between $4.69 and $5.33 in the recent session.

Stock Snapshot

5.28

Prev. Close

109.08M

Market Cap

4.69

Day Low

-1.56

P/E Ratio

-3.21

EPS (TTM)

N/A

Cash Flow per Share

5.33

Open

21.82M

Number of Shares

5.33

Day High

51.23%

Free Float in %

N/A

Book Value

402.27K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	5.33	5.33	4.66	5.00	402.76K
Jul 08, 2026	5.30	5.52	5.02	5.28	255.51K
Jul 07, 2026	5.88	5.89	5.22	5.44	261.75K
Jul 06, 2026	5.59	6.05	5.46	5.99	187.87K
Jul 02, 2026	5.58	5.74	5.19	5.70	210.92K
Jul 01, 2026	5.69	5.99	5.29	5.62	242.61K
Jun 30, 2026	5.15	5.78	5.00	5.76	228.31K
Jun 29, 2026	4.78	5.20	4.70	5.18	168.47K
Jun 26, 2026	5.15	5.53	4.63	4.79	1.66M
Jun 25, 2026	5.05	5.30	4.82	5.06	234.97K
Jun 24, 2026	4.26	5.15	4.24	4.96	308.4K
Jun 23, 2026	4.06	4.45	4.03	4.23	112.17K
Jun 22, 2026	3.96	4.10	3.91	4.08	103K
Jun 18, 2026	3.90	3.98	3.71	3.93	152.64K
Jun 17, 2026	3.85	3.95	3.65	3.82	87.23K
Jun 16, 2026	3.85	4.00	3.72	3.72	107.64K
Jun 15, 2026	3.90	4.10	3.81	3.84	206.3K
Jun 12, 2026	3.64	3.95	3.60	3.90	130.07K
Jun 11, 2026	3.51	3.66	3.40	3.64	91.62K
Jun 10, 2026	3.56	3.69	3.48	3.48	104.75K

Contact Details

San Diego, CA 92122

United States

https://aardvarktherapeutics.com 858 225 7696

About Company

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an agonist, targeting particular bitter taste receptors found within the gut lumen. ARD-101 is currently undergoing a Phase III clinical trial for managing excessive hunger (hyperphagia) associated with Prader-Willi Syndrome. Additionally, it is in a Phase II trial for addressing hyperphagia linked to acquired hypothalamic obesity, often a result of craniopharyngioma treatments like surgery or radiation therapy. Aardvark Therapeutics is also advancing ARD-201, which is currently in Phase I clinical trials for the treatment of obesity. Established in 2017, the company is based in San Diego, California.

Stock Peers

ARGX

-5.81-0.63%

argenx SE$909.49 REGN

5.07+0.76%

Regeneron Pharmaceuticals, Inc.$667.95 MDGL

-5.39-0.95%

Madrigal Pharmaceuticals, Inc.$560.01 UTHR

-1.86-0.34%

United Therapeutics Corporation$552.48 VRTX

-1.93001-0.39%

Vertex Pharmaceuticals Incorporated$496.50 KRYS

-4.15999-1.11%

Krystal Biotech, Inc.$371.24 PRAX

0.13+0.04%

Praxis Precision Medicines, Inc.$333.12 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

7.73+2.45%

Ligand Pharmaceuticals Incorporated$322.61 ALNY

-10.70999-3.31%

Alnylam Pharmaceuticals, Inc.$312.79

Frequently Asked Questions

What is the current Aardvark Therapeutics, Inc. Common Stock (AARD) stock price?

Aardvark Therapeutics, Inc. Common Stock (NASDAQ: AARD) stock price is $5.00 in the last trading session. During the trading session, AARD stock reached the peak price of $5.33 while $4.69 was the lowest point it dropped to. The percentage change in AARD stock occurred in the recent session was -5.3% while the dollar amount for the price change in AARD stock was - $0.28.

AARD's industry and sector of operation?

The NASDAQ listed AARD is part of Biotechnology industry that operates in the broader Healthcare sector. Aardvark Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AARD?

No Data

How AARD did perform over past 52-week?

AARD's closing price is 49.25% higher than its 52-week low of $3.35 where as its distance from 52-week high of $17.94 is -72.13%.

How many employees does AARD have?

Number of AARD employees currently stands at 22.

Link for AARD official website?

Official Website of AARD is: https://aardvarktherapeutics.com

How do I contact AARD?

AARD could be contacted at phone 858 225 7696 and can also be accessed through its website. AARD operates from 4370 La Jolla Village Drive, San Diego, CA 92122, United States.

How many shares of AARD are traded daily?

AARD stock volume for the day was 402.27K shares. The average number of AARD shares traded daily for last 3 months was 194.23K.

What is the market cap of AARD currently?

The market value of AARD currently stands at $109.08M with its latest stock price at $5.00 and 21.82M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	22
Beta	3.93
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

AARD Company Profile and Key Details

Aardvark Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways